Utilizing the immune response to tumor neoantigens for kidney cancer early detection
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110269
- Recipient
-
The Leland Stanford Junior University UEI HJD6G4D6TJY5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $157,700
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Palo Alto, CA 94305, USA
Award details come from USAspending.gov.
About this award
The Leland Stanford Junior University received a $157,700 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research utilizing the immune response to tumor neoantigens for kidney cancer early detection. Through April 2022, Stanford University researchers will investigate medical solutions for the battlefield by exploring the potential of the body's immune response to detect and diagnose kidney cancer at earlier stages. The goal is to transform health care for service members and the public by developing innovative medical research on kidney cancer immunodetection.
Quick answers
Who received award W81XWH2110269?
W81XWH2110269 was awarded to The Leland Stanford Junior University by Medical Command (Department of the Army) on April 15, 2021.
How much is award W81XWH2110269 worth?
$157,700 has been obligated on W81XWH2110269.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award